CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData EP News Bureau Mar 26, 2025 The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…
Sanofi signs distribution pact with Cipla for CNS portfolio in India EP News Bureau Mar 27, 2024 Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium
